Patents Assigned to Salus Therapeutics, Inc.
  • Publication number: 20030144222
    Abstract: Amphiphilic biocompatible cyclodextrin grafted polymers comprising a hydrophobically modified cyclodextrin moiety, a linear linker and a biocompatible hydrophilic polymer backbone, wherein said cyclodextrin moiety is grafted to said biocompatible hydrophilic polymer backbone by said linker are disclosed. The cyclodextrin-grafted biocompatible polymers of this invention may be used as bioactive agent carriers. Methods of making and using such cyclodextrin-grafted biocompatible polymers are disclosed.
    Type: Application
    Filed: November 30, 2001
    Publication date: July 31, 2003
    Applicant: Salus Therapeutics, Inc.
    Inventors: Laixin Wang, Duane E. Ruffner
  • Patent number: 6420144
    Abstract: A method for the automated molecular cloning and amplification of closed circular clones in vitro in a cell-free system using a pair of particularly designed cloning primers in a ligation-during-amplification (LDA) process, in which the fully extended DNA strands containing the donor sequence are ligated by DNA ligase and then used as templates for subsequent amplification. By designing particular cloning primers, the present invention can be used to obtain amplified closed circular nucleic acid clones with inverted or non-inverted insertions or substitutions with a donor nucleic acid fragment, or deletions of a fragment of the closed circular nucleic acid.
    Type: Grant
    Filed: June 28, 2000
    Date of Patent: July 16, 2002
    Assignee: Salus Therapeutics, Inc.
    Inventors: Zhidong Chen, Duane E. Ruffner